Lv1
36 积分 2025-06-10 加入
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
1天前
待确认
Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhibitors: updated results from cohort 5 in the DUBHE-L-201 study
2天前
已完结
Short-term outcomes of multi-arm uniportal robotic thoracic surgery versus uniportal video-assisted thoracoscopic surgery for non-small cell lung cancer
1个月前
已完结
Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single-Cell Transcriptomics
2个月前
已完结
Enhanced immunotherapy response in lung adenocarcinoma patients with COPD: insights into tumor cells and immune microenvironment characteristics
2个月前
已完结
Fruquintinib with programmed cell death - 1 inhibitors versus triflueridine - tipiracil - 102 with bevacizumab in late-line mCRC: A retrospective cohort study based on propensity score matching
2个月前
已完结
Robotic subxiphoid thymectomy versus lateral thymectomy: a propensity score-matched comparison
2个月前
已完结
Robotic-assisted versus video-assisted thoracoscopic surgery for thymic epithelial tumours, from the European Society of Thoracic Surgeons Database
2个月前
已完结
Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis
3个月前
已完结
Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
